Skip to main content
Microorganisms logoLink to Microorganisms
. 2020 May 1;8(5):661. doi: 10.3390/microorganisms8050661

The Microbiome of Peri-Implantitis: A Systematic Review and Meta-Analysis

Philipp Sahrmann 1,*, Fabienne Gilli 1, Daniel B Wiedemeier 2, Thomas Attin 1, Patrick R Schmidlin 1, Lamprini Karygianni 1
PMCID: PMC7284896  PMID: 32369987

Abstract

This review aimed to systematically compare microbial profiles of peri-implantitis to those of periodontitis and healthy implants. Therefore, an electronic search in five databases was conducted. For inclusion, studies assessing the microbiome of peri-implantitis in otherwise healthy patients were considered. Literature was assessed for consistent evidence of exclusive or predominant peri-implantitis microbiota. Of 158 potentially eligible articles, data of 64 studies on 3730 samples from peri-implant sites were included in this study. Different assessment methods were described in the studies, namely bacterial culture, PCR-based assessment, hybridization techniques, pyrosequencing, and transcriptomic analyses. After analysis of 13 selected culture-dependent studies, no microbial species were found to be specific for peri-implantitis. After assessment of 28 studies using PCR-based methods and a meta-analysis on 19 studies, a higher prevalence of Aggregatibacter actinomycetemcomitans and Prevotella intermedia (log-odds ratio 4.04 and 2.28, respectively) was detected in peri-implantitis biofilms compared with healthy implants. Actinomyces spp., Porphyromonas spp. and Rothia spp. were found in all five pyrosequencing studies in healthy-, periodontitis-, and peri-implantitis samples. In conclusion, the body of evidence does not show a consistent specific profile. Future studies should focus on the assessment of sites with different diagnosis for the same patient, and investigate the complex host-biofilm interaction.

Keywords: culture-dependent techniques, hybridization, oral pathogens, PCR, pyrosequencing

1. Introduction

To date, dental implants have shown high survival rates of up to 99% over 10 years [1,2]. Even if much stricter criteria on success are applied, the concept of dental implantology still appears promising [3,4], despite the fact that certain limitations of the relevant techniques become evident. Besides minor prosthetic complications (such as crown loosening or ceramic chipping, which can mostly be resolved easily, and without big effort) peri-implantitis, as the most common reason for biologic failure, is much more challenging [4,5]. The prognosis of peri-implantitis therapy, however, is far away from satisfactory today [6,7]. The key feature of peri-implantitis is the progressive loss of marginal peri-implant bone as a symptom of chronic inflammation of the peri-implant tissues [6]. While particular co-factors, such as diabetes mellitus [8,9], tobacco smoking [10,11], and insufficient oral hygiene [12,13] were found to accelerate the progress of bone destruction, the primary etiologic reason for the inflammation of peri-implant tissues is the oral biofilm [14]. Peri-implantitis-associated biofilms, colonizing exposed implant surfaces, are composed of a plethora of microbial species [15,16]. Accordingly, any cause-related treatment of peri-implantitis aims at effectively removing established microbial biofilms and preventing new biofilm formation [6]. Like in the therapy of periodontal inflammation, which is also biofilm-induced, mechanical biofilm removal has been proven to be the most efficient treatment modality. Therefore, hand instruments, such as scalers or curettes, ultrasonic tips, or air-abrasive devices [6,17], and sometimes different kind of lasers [18], are used. Moreover, antimicrobials have also been used, yet with limited success [19,20]. Both measures, however, mechanical and antiseptic biofilm control, represent very generic treatment strategies and do not conform to the need for individualized, specific, and sophisticated therapy schemes. In general, both therapeutic approaches show strong limitations. In particular, mechanical access for debridement of submucosal areas and narrow infra-bony defects is difficult and cannot be performed to a satisfactory extent [17,21,22]. Antimicrobial agents, on the other hand, are largely ineffective due to the immanent defense mechanisms of mature biofilms, such as osmotic barrier function and downregulation of bacterial metabolism [23], especially if the biofilm infrastructure had not been destroyed previously by mechanical means [24,25]. Gaining more specific insights into the composition of peri-implant biofilm might trigger the development of targeted treatment approaches and, thereby, improve the prognosis of peri-implantitis treatment. Regarding the composition of peri-implantitis-associated biofilm, a number of key pathogens have been strongly associated with the peri-implant inflammation so far. Since suppuration is a characteristic clinical finding in cases of peri-implantitis, Staphylococcus aureus has been suspected to play a major role in the pathology of the disease due to its typical pyogenic potential, which is already well-known in the field of dermatology [26,27]. However, recent studies using modern diagnostic tools and molecular-based identification techniques did not support this hypothesis [28,29]. After comparing the microbiome of healthy and inflamed implant sites, Belibasakis and co-workers found a predominance of three groups of Treponema spp. and a Synergistetes cluster A around diseased implants [30].

However, there is still some controversy among researchers about whether the composition of biofilm in peri-implantitis is really different from the composition of biofilms in periodontitis-affected sites, or even from the microflora around healthy dental implants [29,31,32]. Accordingly, the aim of the present study is to systemically review the relevant literature regarding the composition of biofilm of diseased peri-implantitis sites and to compare the microbiome of healthy sites to that found at sites affected by periodontitis. Additionally, this systematic review aimed to describe the microbiologic profiles of peri-implantitis, periodontitis, and healthy implants based on culture-dependent and culture-independent methods.

2. Materials and Methods

2.1. Review Questions

This systematic review aimed to answer the following focused questions:

  1. Is there a difference between the microbiome associated with implants affected by peri-implantitis and that associated with periodontitis-affected teeth?

  2. Is there a difference between the microbiome associated with implants affected by peri-implantitis and that associated with clinically healthy implants?

  3. What are the microbial profiles of peri-implantitis, periodontitis, and healthy implants, based on culture-dependent and culture-independent methods, from peri-implantitis versus periodontitis, or peri-implantitis versus healthy sites?

Based on the available data, the main hypothesis of this review was that specific microbial species are present, either exclusively or predominantly at peri-implantitis sites, but not around healthy implants or teeth with periodontitis.

2.2. Study Eligibility

For literature search, studies assessing the microbiome of peri-implantitis in systemically healthy patients were considered if microbiological testing included more than one microbial species, and the assessment was based on at least 10 samples per study. For inclusion, clear diagnostic criteria for peri-implantitis were applied. Only original studies were considered while systematic and narrative reviews were excluded. Likewise, studies on in-vitro-biofilms, animal studies and studies on cohorts with specific predisposing factors for peri-implant or periodontal diseases were excluded.

2.3. Search Strategy

An electronic search was conducted in five databases (U.S. National Library of Medicine database (MEDLINE) available online: www.ncbi.nlm.nih.gov/pubmed, Experta Medica Database (EMBASE) available online: www.embase.com, SCOPUS available online: (www.scopus.com), Biosis (available online: www.library.ethz.ch/Ressourcen/Datenbanken/BIOSIS-Previews) and Web of Science (available online: apps.webofknowledge.com)). The search items were divided into the groups peri-implantitis, microbiome, and assessment method, and the search for the respective sub-items was combined with the Boolean operators (OR, AND). The search strategy is reported in detail in Appendix A Literature Search Strategy. The electronic databases were searched from the times of their establishment until May 2019, and the relevant studies were considered for inclusion. There was no language restriction for the literature search.

2.4. Study Selection

In the first step, titles and abstracts yielded from the electronic search were screened and checked for possible inclusion. In the second step, full texts were reviewed in order to decide for or against final inclusion. Both steps were performed by two authors (FG and PS) independently. In case of any discrepancies during title and abstract screening, the respective paper was included to the full-text assessment, while discrepancies during this latter step were resolved by discussion between the authors (PS and FG) conducting the literature search.

2.5. Data Organization

In order to collect and merge the information of the different studies retrieved, a standard document was utilized. In particular, data regarding authors and the year of publication, study type and design, diagnostic criteria, number and type of samples, statistical units, implant systems used, sampling methods, and the microbiological assessment methods were extracted. Likewise, quantitative data regarding the microbiome for cases of peri-implantitis, periodontitis, and healthy implants were extracted.

2.6. Data Quality Assessment

The extracted data were assessed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA) [33]. For each of the included studies, a quality assessment was performed by one investigator (PS) using an adaptation of the modified Newcastle–Ottawa scale [34]. Studies were evaluated regarding the case definition, the selection of the controls and their matching for confounding factors, as well as the blinding of the involved laboratory. A maximum of 7 points could be reached, resulting in a rating of high quality (6–7 points), medium quality (3–5 points), and low quality (0–2 points).

2.7. Data Synthesis

In order to assess literature for consistent evidence of exclusive or predominant peri-implantitis microbiota, statistical comparisons were performed only for microbial species that were assessed and reported in the majority of studies. Results beyond comparable data were analyzed qualitatively in separate sections. Meta-analyses were performed if more than three studies assessing the same bacterial species with sufficient homogeneity were found. Otherwise, weighted means for the (positive) detection of different species for either peri-implantitis or healthy sites were calculated.

2.8. Statistical Analysis

Random-effects meta-analyses using odds-ratios (OR) were performed to investigate if certain species were more prevalent at healthy sites than at peri-implantitis sites and vice-versa. Diagnostic plots (funnel plot, radial plot, standardized residuals, and normal QQ plot) were used to check model assumptions and sources of bias (e.g., publication bias). All meta-analyses and corresponding figures were calculated with the statistical software R [R Core Team, 2018, a language and environment for statistical computing; Available online: https://www.R-project.org/], including the metafor package [35].

3. Results

3.1. Selected and Excluded Reports

After removal of duplicate titles from different electronic libraries, 956 titles were retrieved for possible inclusion. Of these, 158 full texts were analyzed and further 95 studies were excluded for different reasons, such as no assessment of peri-implantitis (n = 37), missing quantification of the results (n = 35), inclusion of less than 10 samples (n = 14), assessment of only one single bacterial species (n = 6), or other reasons (Figure 1). For the screening process inter-rater reliability was 96% before discussion. Finally, data out of 64 studies on 3730 samples from peri-implant sites were extracted over a publication period from 1990 to 2019. More than 70% of these studies had been published in the past eight years. In the selected studies, different assessment methods were described, namely bacterial culture, PCR-based assessment, hybridization techniques, pyrosequencing, and transcriptomic analyses. While culture-dependent (44%) and hybridization techniques (44%) were the most frequently applied microbiological techniques for the studies published prior to 2011, culture-independent techniques, e.g., PCR, hybridization, pyrosequencing, and transcriptomics (42%), were predominantly described in studies published after 2011. Quality assessment revealed 9 studies of high, 25 of medium, and 30 of low quality, respectively (Table 1). In 59 out of 64 studies, sampling was performed using sterile paper points and/or curettes in the vast majority of cases. Few data were available regarding the type of investigated implants. A total of 17 studies, however, reported microbiological data on titanium implants.

Figure 1.

Figure 1

Search strategy.

Table 1.

Quality assessment.

Author and Date of Publication Case Definition Selection of Controls Matched for Bias Assessment of Outcome Score Quality
Albertini et al., 2015 [36] 2 2 0 0 4 Medium
Alcoforado 1990 [37] 1 0 0 0 1 Low
Arisan et al., 2015 [38] 2 0 0 0 2 Low
Ata-Ali et al., 2015 [39] 2 1 1 0 4 Medium
Augthun et al., 1997 [40] 1 0 0 0 1 Low
Bassetti et al., 2014 [41] 2 0 0 0 2 Low
Becker et al., 1990 [42] 1 0 0 0 1 Low
Bertone et al., 2016 [43] 2 0 0 0 2 Low
Birang et al., 2017 [44] 2 0 0 0 2 Low
Bombeccari 2013 [45] 2 0 0 0 2 Low
Botero et al., 2005 [46] 2 1 2 0 5 Medium
Caccianiga et al., 2016 [47] 1 0 0 0 1 Low
Canullo et al., 2013 [48] 2 1 2 0 5 Medium
Canullo et al., 2015a [49] 2 0 0 0 2 Low
Canullo et al., 2015b [50] 2 1 2 0 5 Medium
Canullo et al., 2017 [51] 2 1 2 0 5 Medium
Casado et al., 2011 [52] 1 1 2 0 4 Medium
Charalampakis et al., 2012 [53] 2 0 0 0 2 Low
Cortelli et al., 2013 [54] 2 2 2 0 6 High
da Silva et al., 2014 [55] 2 1 2 0 5 Medium
Dabdoub et al., 2013 [56] 2 2 2 0 6 High
de Waal et al., 2014 [57] 2 0 0 0 2 Low
de Waal et al., 2017 [58] 2 1 2 0 5 Medium
Dörtbudak et al., 2011 [59] 2 0 0 0 2 Low
Ebadian et al., 2012 [60] 2 1 2 1 6 High
Faveri et al., 2011 [61] 2 1 2 0 5 medium
Gurlek et al., 2017 [62] 2 2 2 0 6 high
Hultin et al., 2002 [63] 1 1 2 0 4 medium
Isehed et al., 2016 [64] 2 0 0 0 2 low
Jankovic et al., 2011 [65] 2 1 2 0 5 medium
Kumar et al., 2012 [66] 2 1 2 0 5 medium
Leonhardt et al., 1999 [67] 2 1 2 0 5 medium
Leonhardt et al., 2003 [68] 2 0 0 0 2 low
Maruyama et al., 2014 [69] 2 2 2 0 6 high
Maximo et al., 2009 [70] 2 1 2 1 6 high
Mombelli et al., 2001 [71] 2 0 0 0 2 low
Neilands et al., 2015 [72] 2 1 1 1 5 high
Parthiban et al., 2017 [73] 2 1 1 0 4 medium
Passariello et al., 2012 [74] 1 0 0 0 1 low
Persson et al., 2006 [75] 1 0 0 0 1 low
Persson et al., 2010 [76] 2 0 0 0 2 low
Persson et al., 2011 [77] 2 0 0 0 2 low
Renvert et al., 2006 [78] 2 0 0 0 2 low
Renvert et al., 2007 [79] 2 1 2 0 5 medium
Renvert et al., 2009 [80] 2 0 0 0 2 low
Renvert et al., 2015 [10] 1 0 0 0 1 low
Renvert et al., 2017 [81] 2 0 0 0 2 low
Salcetti et al., 1997 [82] 1 1 1 1 4 medium
Sato et al., 2011 [83] 2 0 0 0 2 low
Sbordone et al., 1995 [84] 2 0 0 0 2 low
Schmalz et al., 2016 [85] 2 1 1 0 4 medium
Schwarz et al., 2015 [86] 2 1 1 0 4 medium
Shiba et al., 2016 [87] 2 2 2 0 6 high
Shibli et al., 2008 [88] 2 1 2 0 5 medium
Tada et al., 2017 [89] 2 0 0 0 2 low
Tsigarida et al., 2015 [90] 1 1 1 0 3 medium
Verdugo et al., 2015 [91] 2 2 2 0 6 high
Zhuang et al., 2016 [92] 2 2 2 0 6 high
Ziebolz et al., 2017 [93] 2 1 2 0 5 medium

3.2. Culture-Dependent Techniques

In a total of 13 studies using culture techniques, Porphyromonas gingivalis, Tannerella forsythia, Prevotella intermedia, Parvimonas micra, Fusobacterium nucleatum, Campylobacter rectus, Aggregatibacter actinomycetemcomitans, Eikenella corrodens and Candida albicans were compared, and weighted means for detection frequencies were calculated. Nine studies analyzed solely the microbiome of peri-implantitis cases, while four studies compared the respective findings of peri-implantitis-associated versus healthy implants. The yeast C. albicans was the only species that could not be retrieved from the tested peri-implantitis samples, but solely from healthy implant sites. After the analysis of all selected culture-dependent studies, no microbial species were found to be specific or characteristic for peri-implantitis.

A considerable heterogeneity regarding the statistical unit, i.e., whether one or more samples per patient had been taken, and considerable differences in culture techniques was found. Accordingly, a reasonable meta-analysis was not possible in order to assess potential statistical differences regarding the positive detection of specific microbial species between health periodontal and peri-implant disease.

However, the use of weighted means from single studies to illustrate the overall results revealed that the majority of microbial species was detected more frequently in healthy sites, while Eikenella corrodens prevailed in peri-implantitis samples (Figure 2). The latter was reported in a high-quality study by Leonhard et al. (1999), in which samples from healthy and peri-implantitis sites of the same patient were directly compared. Table 2 provides an overview of reports assessing different microbial species using culture-dependent methods.

Figure 2.

Figure 2

Frequency of positive detection in studies performing culture-based assessment. Weighted percentages of positive assessment in samples from healthy and peri-implantitis sites (bars = means, whiskers = standard deviation).

Table 2.

Studies assessing different species using culture-based techniques.

Author and Date of Publication Assessed Situation P. gingivalis T. forsythia P. intermedia P. micra F. nucleatum C. rectus A. actinomycetemcomitans E. corrodens C. albicans n
Studies assessing only peri-implantitis-affected sites
Alcoforado et al., 1990 [37] PI x x 22% 33% x x 6% x 28% 18
Augthun et al., 1997 [40] PI x x 28% x 22% x 89% 17% x 18
Bombeccari et al., 2013 [45] PI 100% x 100% x x x 78% x x 40
Charalampakis et al., 2012 [53] PI 9% x 52% x x x 13% x 3% 281
de Waal et al., 2013 [57] PI 15% 21% 14% 69% 50% 15% 0% x x 78
Dortbudak et al., 2011 [59] PI 100% x 100% x x x 100% x x 15
Leonhardt et al., 2003 [68] PI 4% x 38% x x x 54% x 0% 26
Mombelli et al., 2001 [71] PI 17% 37% 55% x x 56% 0% 0% x 30
Passariello et al., 2012 [74] PI x x x x x x x x x 128
Studies comparing healthy sites with peri-implantitis-affected sites
Botero et al., 2005 [46] PI 44% x 25% * x x x x 0% x 16
HI 0% x 7% * x x x x 7% x 15
de Waal et al., 2017 [58] PI 25% 60% 50% 90% 95% 20% 4% x x 85
HI 12% 10% 5% 70% 75% 10% 2% x x 69
Leonhardt et al., 1999 [67] PI 8% x 60% x x x 27% x 8% 37
HI 2% x 18% x x x 2% x 0% 51
Neilands et al., 2015 [72] PI x x x x x x x x x 25
HI x x x x x x x x x 25

HI—healthy implants, PI—implants with peri-implantitis, x not assessed, n—number of samples assessed for the respective study. * No differentiation of P. intermedia and P. nigrescens.

3.3. Hybridization Techniques

Fifteen studies describing hybridization techniques to assess different genera were retrieved. No meta-analysis could be performed for all relevant studies due to heterogeneity in the data presentation. Instead, the results of only twelve studies could be compared in terms of weighted means for positive detection frequencies. In all peri-implantitis samples, Campylobacter spp., Fusobacterium spp., Gemella spp., Porphyromonas spp., Parvimonas spp., Treponema spp. and Veillonella spp. could be identified, while Prevotella spp., Staphylococcus spp. and Streptococcus spp. were detected in 60%–80% of samples (Figure 3 and Table 3). No conclusive differences between samples from healthy implants or peri-implantitis could be found.

Figure 3.

Figure 3

Frequency of positive detection in studies performing hybridization-based assessment. Weighted percentages of positive assessment in samples from healthy and peri-implantitis sites (bars = means, whiskers = standard deviation).

Table 3.

Studies assessing different species using PCR-based techniques.

Author and Year of Publication Assessed Situation P. gingivalis T. forsythia T. denticola P. intermedia P. micra P. nigrescens F. nucleatum C. rectus E. nodatum A. actinomycetemcomitans E. corrodens C. albicans n
Study comparing peri-implantitis sites with periodontitis sites
Albertini et al., 2015 [36] PI 66 75 39 24 x x x x x 0 x x 33
PER 48 60 27 27 x x x x x 0 x x 33
Studies comparing healthy sites with peri-implantitis-affected sites
Ata-Ali et al., 2015 [39] PI 37 33 33 x x x x x x x x x 24
HI 11 17 17 x x x x x x x x x 54
Canullo et al., 2015 [49] PI 57 75 65 75 97 x 99 86 x 0 75 17 113
HI 67 80 43 77 97 x 97 77 x 3 53 10 122
Casado et al., 2011 [52] PI 80 90 70 70 x x x x x 40 x x 10
HI 90 80 70 40 x x x x x 30 x x 10
Sato et al., 2011 [83] PI 86 76 76 x x x x x x 14 x x 29
HI 5 10 10 x x x x x x 0 x x 21
Schmalz et al., 2016 [85] PI 67 60 47 x x x 93 x x 20 x x 15
HI 80 53 27 x x x 93 x x 13 x x 15
Ziebolz et al., 2017 [93] PI 69 62 50 50 31 x 93 6 0 25 6 x 16
HI 63 46 27 17 16 x 83 4 1 10 8 x 115
Bertone et al., 2016 [43] PI x x x x x x x x x x x 83 18
HI x x x x x x x x x x x 59 22
Schwarz et al., 2015 [86] PI x x x x x x x x x x x 32 19
HI x x x x x x x x x x x 40 10
Verdugo et al., 2015 [91] PI 61 96 78 44 x 78 x x x 13 x x 23
HI 65 87 35 30 x 65 x x x 13 x x 23
Kato et al., 2017 [94] PI 60 x x x x x x x x x x x 15
HI 93 x x x x x x x x x x x 15
Studies assessing peri-implantitis sites only
Arisan et al., 2015 [38] PI 77 92 100 83 92 88 100 83 0 x x x 48
Bassetti et al., 2014 [41] PI 38 60 45 30 68 x 95 58 55 35 55 x 40
Becker et al., 1990 [42] PI 38 x x 35 x x x x x 28 x x 36
Caccianiga et al., 2016 [47] PI 90 80 70 x x x 80 100 x 10 80 x 10
Studies comparing peri-implantitis sites with periodontitis sites and healthy implants
Cortelli et al., 2013 [54] PI 54 40 54 32 x x x 70 x 42 x x 50
PER 72 100 76 56 x x x 98 x 4 x x 50
HI 6 32 12 12 x x x 98 x 4 x x 53
Zhuang et al., 2016 [92] PI 32 x 18 5 x x 77 x x 9 x x 22
PER 32 x 23 5 x x 77 x x 14 x x 22
HI 23 x 14 0 x x 64 x x 0 x x 22

PI—implants with peri-implantitis, HI—healthy implants, PER—teeth with periodontitis, x not assessed, n—number of samples assessed for the respective study.

3.4. PCR-Based Assessment

Twenty-eight studies that used PCR-based methods were selected for assessment. Due to a considerable homogeneity of the studies, a meta-analysis could be performed to assess the prevalence of A. actinomycetemcomitans, P. intermedia, and T. forsythia based on five, six, and eight comparable studies, respectively. The species A. actinomycetemcomitans was found to be prevalent in peri-implantitis with a significantly higher log-odds ratio (4.04) as compared to healthy implants (Figure 4). Regarding P. intermedia (Figure 5), the log-odds ratio for peri-implantitis was also significantly higher (2.28) than for healthy implants, although meta-analysis diagnostics could also indicate some publication bias (funnel and Galbraith plot, Figure S1). For T. forsythia, the prevalence turned out to be only slightly higher for peri-implantitis, failing to show significance with a log-odds ratio of 1.70 (Figure 6), which was even lower (1.03) if one considered the study by Sato et al., 2011 [83] as an outlier. Data for P. gingivalis, T. forsythia, Treponema denticola, P. intermedia, P. micra, Prevotella nigrescens, F. nucleatum, C. rectus, Eubacterium nodatum, A. actinomycetemcomitans, E. corrodens, and C. albicans were assessed in the retrieved studies. Of these, 17 studies allowed for the comparison of weighted mean values for positive detection frequencies (Figure 7). Eleven studies compared results between healthy implants and implants affected by peri-implantitis, while two studies compared peri-implantitis with periodontitis samples. Four further studies analyzed samples only from peri-implantitis sites. Notably, none of the assessed microbial species was exclusively found in either peri-implantitis, healthy implants, or periodontitis samples. In exception for P. nigrescens and E. nodatum, which slightly prevailed in peri-implantitis samples, the prevalence of P. gingivalis, T. forsythia, T. denticola, P. intermedia, P. micra, F. nucleatum, C. rectus, A. actinomycetemcomitans, E. corrodens, and C. albicans was similar in health and disease (Table 4).

Figure 4.

Figure 4

Meta-analysis for the presence of Aggregatibacter actinomycetemcomitans in either healthy sites or peri-implantitis sites (studies performing PCR-based analysis). HI—healthy implants, PI—implants with peri-implantitis, Q—Cochrane’s Q, df—degrees of freedom, p—level of significance, I2—proportion of observed variance (heterogeneity).

Figure 5.

Figure 5

Meta-analysis for the presence of Porphyromonas gingivalis in either healthy sites or peri-implantitis sites (studies performing PCR-based analysis). HI—healthy implants, PI—implants with peri-implantitis, Q—Cochrane’s Q, df—degrees of freedom, p—level of significance, I2—proportion of observed variance (heterogeneity).

Figure 6.

Figure 6

Meta-analysis for the presence of Tannerella forsythia in either healthy sites or peri-implantitis sites (studies performing PCR-based analysis). HI—healthy implants, PI—implants with peri-implantitis, Q—Cochrane’s Q, df—degrees of freedom, p—level of significance, I2—proportion of observed variance (heterogeneity).

Figure 7.

Figure 7

Frequency of positive detection in studies performing PCR-based assessment. Weighted percentages of positive assessment in samples from healthy and peri-implantitis sites (bars = means, whiskers = standard deviation).

Table 4.

Studies assessing different species using hybridization techniques.

Author and Year of Publication Assessed Situation Actinomyces spp. Campylobacter spp. Fusobacterium spp. Gemella spp. Parvimonas spp. Porphyromonas spp. Prevotella spp. Staphylococcus spp. Streptococcus spp. Tannerella spp. Treponema spp. Veillonella spp. n
Studies comparing healthy sites with peri-implantitis-affected sites
Hultin et al., 2002 [63] PI x 71 100 x x 65 100 x 88 x 41 x 17
HI x 64 100 x x 79 93 x 71 x 43 x 14
Maximo et al., 2009 [70] PI + + + + + + + x + + + + 13
HI + - + + + - + - + + + + 10
Renvert et al., 2007 [79] PI 5.9 8.7 44.5 x x x 18 13 4.7 4.3 8.7 13 213
HI 2.9 3.7 44. 7 x x x 26.3 7.8 2.6 2.6 13.2 18.4 213
Shibli et al., 2008 [88] PI + + + + + + + x + + + + 22
HI x + + + + x + x + + x + 22
Ata-Ali et al., 2015 [39] PI x x x x x 37.5 x x x 33.3 33.3 x 24
HI x x x x x 11.1 x x x 22.2 16.7 x 54
Salcetti et al., 1997 [82] PI + + 69.6 x + + 87 x 47.8 + + x 21
HI + + 14.3 x + + 28.6 x 0 8
Studies comparing peri-implantitis sites with periodontitis sites and healthy implants
Ebadian et al., 2012 [60] PI + 15.4 38.5 x x 53.8 30.8 x x 61.5 x x 13
PER + 0 61.5 x x 30.8 30.8 x x 46.1 x x 13
HI + 59.1 72.7 x x 90.9 90.9 x x 90.9 x x 21
Studies assessing only peri-implantitis
Charalampakis et al., 2012 [53] PI + + + x + + + x + + + x 257
Persson et al., 2006 [75] PI + x + + + + + x + + x 25
Persson et al., 2011 [77] PI + + + x + + + + + + + + 37
Renvert et al., 2006 [78] PI + + + x x + + + x + + x 32
Renvert et al., 2008 [26] PI + + + x + + + x + + + x 37
Renvert et al., 2015 [95] PI + + + x x x + + + + x x 41
Renvert et al., 2017 [81] PI + + + x + x x + + + x x 41

PI—implants with peri-implantitis, HI—healthy implants, PER—teeth with periodontitis, spp.—species, + positive detection, - no detection, x not assessed, n—number of samples assessed for the respective study.

Although the study by Yu et al. [96] posed the same focused question as the present review, the presentation of the results data did not allow for the inclusion of the study in the meta-analysis. In this study, the vast majority of microorganisms found in both peri-implantitis and healthy implant sites were spirochetes, with a proportion of 97.6%. Likewise, a total of 31 so-called “core-species”, including the above-mentioned microbial species, were found in more than 90% of both peri-implantitis and healthy samples. Beta-diversity analyses revealed the largest variance on the subject level. Differences regarding health status of the respective sites were reflected by differences of operational taxonomic units (OTUs) of Prevotella spp., Porphyromonas spp., Tannerella spp. and Treponema spp. In an earlier report, Belibasakis et al., 2016 reported that Treponema cluster 1 and a cluster A of Synergistetes, a gram-negative anaerobic rod, were highly associated with peri-implantitis [30].

3.5. Pyrosequencing

Overall, the selected reports differed considerably from each other regarding their focused question, genera assessment, data presentation, and outcomes. Therefore, meta-analysis with data of the respective studies was reasonable only for a limited selection of sufficient homogeneity. In five studies, bacterial assessment was performed by pyrosequencing, allowing for positive detection of the following genera: Actinomyces spp., Campylobacter spp., Fusobacterium spp., Gemella spp., Parvimonas spp., Porphyromonas spp., Prevotella spp., Rothia spp., Staphylococcus spp., Streptococcus spp., Treponema spp., and Veillonella spp. Of these, Actinomyces spp., Porphyromonas spp., and Rothia spp. were found in all studies in samples from healthy sites, periodontitis sites, and peri-implantitis sites. The genera Campylobacter spp. and Gemella spp., likewise, were present in all samples collected from healthy sites. However, one report that did not assess samples from healthy controls failed to detect species of these genera in periodontitis or peri-implantitis samples [69]. Interestingly, Fusobacterium spp. and Veillonella spp. were detected in all studies investigating peri-implantitis and periodontitis samples except from one study [66], in which the respective species were not found in samples from healthy sites. Genera showing any specificity, i.e., complete absence or presence in either peri-implantitis or healthy implant or periodontitis samples, were not found (Table 5).

Table 5.

Studies assessing different species using pyrosequencing.

Author and Year of Publication Assessed Situation Actinomyces spp. Campylobacter spp. Fusobacterium spp. Gemella spp. Parvimonas spp. Porphyromonas spp. Prevotella spp. Rothia spp. Staphylococcus spp. Streptococcus spp. Tannerella spp. Treponema spp. Veillonella spp. n
Studies comparing healthy sites with peri-implantitis-affected sites
Da Silva et al., 2014 [55] PI + + + + + + - + - - - - + 10
HI + + + + + + - + - - - - + 10
Tsigarida et al., 2015 [90] PI + + + + + + + + + + + + + 40
HI + + + + + + + + + + + + + 20
Zheng et al., 2015 [97] PI + x + + x x x x x x x + + 6
HI + x - + x x x x x x x - + 10
Studies comparing healthy sites with peri-implantitis-affected and periodontitis-affected sites
Dabdoub et al., 2013 [56] PI + + + + - + + + + + + + + 20
HI + + + + - + + + + + + + + 12
PAR + + + + - + + + + + + + + 17
Kumar et al., 2012 [66] PI + + + + + + + + + + - + + 10
HI + + - + + + + + - + - + - 10
PER + + + + + + + + + + - + + 10
Study comparing peri-implantitis sites with periodontitis sites
Maruyama et al., 2014 [69] PI + - + - + + + + + + + + + 20
PER + - + - + + + + + + + + + 20
Shiba et al., 2016 [87] PI + + - - + + + + - + + + - 12
PER + + - + + + + + - + + + + 12

PI—implants with peri-implantitis, HI—healthy implants, PER—teeth with periodontitis, spp. —species, + positive detection, - no detection, x not assessed, n—number of samples assessed for the respective study.

In a recent report [90], Prevotella spp., Staphylococcus spp., Tannerella spp., and Treponema spp., were detected among other genera in both healthy and peri-implantitis samples, whereas da Silva et al. [55] identified the aforementioned genera in neither healthy nor peri-implantitis samples. Nevertheless, the latter study reported statistically significant differences between certain genera, i.e., lower levels of Actinobacteria spp. and higher levels of Bacterioidetes spp. at peri-implantitis sites as compared to healthy implant sites.

In an earlier study, Tsigarida et al. [90] investigated, primarily, the effect of smoking on 79 different microbial species from 80 partially edentulous subjects with peri-implant health or disease, and identified high proportions of several putative pathogens in the biofilm of smokers. In general, peri-implantitis samples were reported to show a non-specified broader abundance of disease-associated microbial species than samples from healthy sites. Moreover, inter-individual discrepancies between the microbiome of peri-implantitis, and periodontitis within individual patients, were highlighted by Dabdoub et al. [56] and Kumar et al. [66], who confirmed the presence of a significantly broader microbial diversity in periodontitis compared to peri-implantitis. The group of Kumar et al. pointed out that previously unknown species were only identified in samples from peri-implantitis sites, while higher levels of Actinomyces spp., Peptococcus spp., Campylobacter spp., Streptococcus spp. and Butyrivibrio spp. were detected in biofilms from peri-implantitis as compared to those at healthy implants. However, Murayama et al. revealed the presence of higher proportions of P. nigrescens, yet lower proportions of Peptostreptococcaceae spp. and Desulfomicrobium orale in peri-implantitis than in periodontitis, respectively [69].

A recent study of Kröger and coworkers showed that the pocket depth has a relevant effect on the microbiome of the peri-implantitis sites, highlighting a pronounced dysbiosis in deeper pockets, while other species, Acinetobacter spp. and Rhodobacteraceae spp., were detected exclusively in pockets of less than 8 mm of depth [98].

3.6. Metatranscriptomic Analysis

In one single study [87], meta-transcriptomic analysis was applied to analyze the microbiome of peri-implantitis biofilms. The genera identified in twelve samples from healthy and peri-implantitis affected implant sites were Actinomyces spp., Campylobacter spp., Fusobacterium spp., Gemella spp., Parvimonas spp., Porphyromonas spp., Prevotella spp., Rothia spp., Staphylococcus spp., Streptococcus spp., Tannerella spp., Treponema spp., and Veillonella spp. (Table 6). However, the genera Gemella spp. and Veillonella spp. was not found in peri-implantitis sites.

Table 6.

Studies assessing different species using metatranscriptomic analysis.

Author and Year of Oublication Assessed Situation Actinomyces spp. Campylobacter spp. Fusobacterium spp. Gemella spp. Parvimonas spp. Porphyromonas spp. Prevotella spp. Rothia spp. Staphylococcus spp. Streptococcus spp. Tannerella spp. Treponema spp. Veillonella spp. n
Study comparing peri-implantitis sites with periodontitis sites
Shiba et al., 2016 [87] PI + + - - + + + + - + + + - 12
PER + + - + + + + + - + + + + 12

PI—implants with peri-implantitis, PER—teeth with periodontitis, spp. —species, + positive detection, - no detection, n—number of samples assessed for the respective study.

3.7. Pathogen-Specific Analysis

A total of five studies aimed to specifically assess S. aureus in samples from peri-implantitis. Of these, one report compared peri-implantitis sites with healthy implant sites and another study described the difference between peri-implantitis and periodontitis sites (Table 7). One report highlighted the detection of Archaea spp., which were found four times more frequently in peri-implantitis samples than in samples from healthy sites (Table 8). Viruses were assessed in four studies. Human cytomegalovirus (CMV) was detected in much higher proportions in 2 out of 3 studies, while Epstein–Barr virus (EBV) was identified in peri-implantitis samples in all three studies. Herpes simplex virus (HSV) was assessed in one study, only in 33% of peri-implantitis sites, and 24% of healthy sites, respectively.

Table 7.

Studies specifically assessing S. aureus.

Author and Year of Publication Positive Assessment of S. aureus [%] n
Cultivation-based assessment
Charalampakis et al., 2012 [53] PI 8.9 281
Leonhardt et al., 1999 [67] PI 0 37
HI 0 51
Leonhardt et al., 2003 [68] PI 11 9
Passariello et al., 2012 [74] PI 18.75% 62.5
PCR-based assessment
Zhuang et al., 2016 [92] PI 77.3 22
HI 72.7 22
PER 68.2 22

PI—implants with peri-implantitis, HI—healthy implants, PER—teeth with periodontitis, spp.—species, n—number of samples assessed for the respective study.

Table 8.

Studies assessing archaea and virus.

Author and Date of Publication Archaea Virus n
HCMV (HCMV1/HCMV2) EBV (EBV1/EBV2) HSV
Cultivation-based assessment
Faveri et al., 2011 [61] PI 48 x x x 25
HI 12 x x x 25
Jankovic et al., 2011a [65] PI x 65 45 x 20
HI x 6 11 x 18
Jankovic et al., 2011b [99] PI x 33/53 7/10 x 30
HI x 8/0 4/8 x 25
Parthiban et al., 2017 [73] PI x x x 33 77
HI x x x 24 113
Verdugo et al., 2015 [91] PI x 4 39 x 23
HI x 4 17 x 23

PI—implants with peri-implantitis, HI—healthy implants, x not assessed, n—number of samples assessed for the respective study, HCMV—human cytomegalovirus, EBV—Epstein–Barr virus, HSV—herpes simplex virus.

4. Discussion

In this systematic review, the relevant literature on the microbiome of peri-implantitis biofilm, comparing its composition with that of biofilms collected from healthy implant sites and periodontitis sites, was reviewed. The meta-analyses were performed to assess the prevalence of A. actinomycetemcomitans, P. intermedia, and T. forsythia, revealing generally higher chances of occurrence in peri-implantitis biofilms as compared to either periodontitis samples or healthy implants. Nevertheless, after taking diverse microbiological methods described in the selected studies into consideration, the presence of a characteristic peri-implantitis-related microbiome could not be confirmed, as the majority of reports did not show a substantial and consistent difference in the prevalence of specific microbial species between health and disease. Notably, several studies emphasized on the detection frequency of single microbial species, again without showing any consistency when comparing either all studies or studies using the same methods for microbial identification and qualification. Therefore, our main hypothesis, suggesting that there are specific microbial species that would exclusively, or at least predominantly, reside in the biofilm of implants with peri-implantitis only, was not confirmed due to absence of consistent evidence. Generally, there are some inconsistent indications from single studies that peri-implantitis might have a broader microbial spectrum than periodontitis, while studies describing culture-dependent techniques did not confirm these findings. Furthermore, the outcomes from hybridization techniques highlighted the presence of equally distributed taxa in health and disease. All PCR-based results failed to detect E. nodatum at healthy sites while Fusobacterium spp., Staphylococcus spp., Veillonella spp. [66], and Treponema spp. [98] were not detected at healthy sites using pyrosequencing. In another report on metatranscriptomic analysis, Gemella spp. and Veillonella spp. could not be identified in peri-implantitis samples [87]. Regarding viruses, however, consistently high counts of EBV and human cytomegalovirus (HCMV) were recovered from peri-implantitis biofilms [65,91,99].

A recent retrospective study analyzed the microbiological composition of about 500 biofilm samples from implants and their adjacent periodontium ten years after implant loading, using PCR amplification and hybridization [100]. As a result, a broad range of congruence (6.2%–78.4%) was measured in samples from peri-implant and periodontal pockets. In peri-implant samples, higher levels of T. forsythia, P. micra, F. nucleatum, Fusobacterium necrophorum, and C. rectus were found as compared to periodontitis sites. After comparing inflamed peri-implant sites with healthy ones, a higher prevalence of P. intermedia, T. denticola, C. rectus, and Staphylococcus warneri was found at inflamed sites. Smokers were characterized by a higher microbial diversity than non-smokers both in health and disease. The results of this retrospective study are in accordance with the findings of the present meta-analysis regarding both the absence of any specificity of the peri-implantitis microbiome and the high prevalence of P. intermedia. The submucosal prevalence of P. intermedia in diseased peri-implant sites versus healthy sites was confirmed in a further case-control study [58].

In general, a considerable heterogeneity of the selected studies regarding the microbial analysis method and study design, especially in terms of retrieval from comparative samples from either different cohorts or from the same individual, was found. Results obtained from different microbiological methods do not allow for a direct comparison of the respective outcomes, even though each technique has its specific advantages and disadvantages. While culture-dependent techniques were applied until the early 2000s, modern techniques based on specifying DNA sequences have allowed for more comprehensive microbiological screening in the last two decades. Additionally, other sophisticated techniques, such as pyrosequencing, allowed for the assessment of a much broader range of oral microbiota both in health and disease. Since different microbiological techniques aim also at different targets, i.e., the multiplication of vital bacteria, the detection of few “key pathogens” or the broadest possible range of analysis, a direct comparison between results from different microbiological techniques, is not indicated. Accordingly, the microbiome of peri-implantitis is characterized by a high microbial diversity consisting of both Gram-positive aerobe rods, Gram-negative anaerobic, and fusiform pathogens.

Moreover, reports on culture-based techniques did not reveal any specificity for the composition of biofilms from samples of peri-implantitis as compared to periodontitis or healthy implants, with the exception of the recovery of C. albicans only from healthy implants. Several studies support the existence of a higher microbial diversity in samples from healthy sites. Microbiological techniques that use specific DNA sequences, such as hybridization or PCR analysis, likewise, did not reveal a specificity of any species in health or disease. Only P. nigrescens and E. nodatum were identified more frequently in samples from peri-implantitis. Likewise, single studies indicated a high association of sub-clusters of Treponema spp. and Synergistetes spp. with peri-implantitis [30].

The decisive advantage of pyrosequencing is the ability to assess the entire microbiome as registered in the relevant libraries, including non-cultivable microbial species and, thereby, to comprehensively characterize the biofilm composition [66,101]. According to the results of studies using pyrosequencing, all tested species were positively tested in samples from healthy implants, peri-implantitis and periodontitis biofilms, with the only exception of Campylobacter spp. and Gemella spp., which were absent in samples from healthy implants in only one study [69].

No specific genera were found for the different groups. Generally speaking, if a species could not be found in either health or disease, in most cases it was also not detectable in the other respective state of health. Nevertheless, there are single studies that report a higher microbial diversity in general. More specifically, the prevalence of Bacteroidetes spp. [102], Actinomyces spp., Peptococcus spp., Campylobacter spp., Streptococcus spp., and Butyrivibrio spp. [56] in peri-implantitis than in healthy implant sites has been highlighted. Another report demonstrated higher counts of P. nigrescens and lower counts of Peptostreptococcaceae spp. and Desulfomicrobium orale in peri-implantitis samples than periodontitis sites. However, it is noteworthy that other reports assessing the same microbial species reported controversial results [55,90] for the prevalence of several bacterial species, namely Prevotella spp., Staphylococcus spp., Tannerella spp., and Treponema spp. Interestingly, the only study performing meta-transcriptomic assessment failed to detect Gemella spp. and Veillonella spp. in peri-implantitis samples, implying the absence of specificity of the according species.

Another study explicitly investigated the presence of Archaea spp. by PCR [31]. The detection frequency of Archaea spp. turned out to be slightly more frequent in peri-implantitis than in healthy sites. Due to the moderate difference between health and disease, however, archaea may not serve as a key species in the etiology of peri-implantitis. The presumable behavior of archaea as environmental modifiers in periodontal and peri-implant disease needs further investigation. Consistently, EBV was more frequent in peri-implantitis samples in three studies using PCR, indicating a potential role of the virus in the pathogenesis of peri-implantitis. [65,91,99]

All selected reports described standardized conventional microbiologic methods and reported exact (81%) or at least satisfying criteria (19%) for the diagnosis of peri-implantitis. This was confirmed by marginal bone loss on radiographs and pocket depths of more than 4–5 mm, absence of bleeding-on-probing or validated progression as an important indicator for the actual peri-implant inflammation. Quality assessment revealed a relatively high number of studies of low quality (48%). Notably, this outcome does not result from an inaccurate assessment or data presentation, but from the fact that solely peri-implantitis samples without controls from healthy or periodontally affected sites were considered. An adequate matching of the cohorts of different groups and control of confounders was performed in 43% of studies. Only 7% of the retrieved studies reported blinding during microbiological tests with regard to the group allocation.

Keeping these points in mind, it is obvious that the onset and progression of peri-implantitis is certainly not merely dependent on the composition of the related biofilms, but might depend on risk factors (e.g., smoking), and diseases affecting general health (e.g., diabetes mellitus), which have been revealed by a broad body of evidence [103]. Furthermore, other factors that are more difficult to assess are also likely to influence peri-implant health, e.g., psychic stress and nutrition. The latter are known to substantially influence the course of other chronic and especially inflammatory diseases [104,105].

The evaluation of the publication date of the retrieved studies revealed that first reports were published in the 1990s, while there was an abrupt rise in numbers of publications starting from the year 2010. Culture-dependent techniques have been predominantly used until the beginning of 2000, since PCR and hybridizations techniques were established at that time. More sophisticated microbiological techniques, such as pyrosequencing, have been developed since 2012, while metatranscriptomics have been applied since 2016. Each of these techniques constitutes a valid assessment method with specific emphasis on either complex determination of the whole microbiome, quick and less expensive assessment, or detection of probably unknown microbial species. A comparison of the results from studies on different microbiological techniques, however, is problematic due to the different questions that might be answered by the different techniques. Yet, a comparative report on oral microbiota revealed that results from cultivation and hybridization do not seem to perfectly match with each other [53]. The finding that the microbial profile of peri-implantitis does not display consistent characteristics is in accordance with a literature review by Lafaurie et al. [29].

Acknowledgments

The authors thank Thomas Thurnheer for his expertise and constructive advice.

Supplementary Materials

The following are available online at https://www.mdpi.com/2076-2607/8/5/661/s1, Figure S1: funnel and Galbraith plot for the presence of P. intermedia in the different studies.

Appendix A. Literature Search Strategy

English search items were divided into the groups “peri-implantitis”, “microbiome”, and “method of analysis”, and the individual search items were combined by boolean operators (OR, AND) based on the search strategy for MEDLINE; the search was performed for each of the data sources.

Disease: exp Peri-Implantitis/or (periimplant* or peri-implant* or “peri implant*).ti,ab. or (dental adj3 implant adj3 (inflam* or infect*)).ti,ab.

Etiology: exp Microbiota/or exp Bacterial Infections/ or exp Bacteria/or exp Dental Plaque/or exp Biofilms/or (Microbiome or microbiota or microbes or microbiology or microflora or bacteria or pathogens or genome or microorganisms or aerobic or anaerobic or “Gram positive” or Gram-positive or “Gram negative” or Gram-negative or species or ecosystem or ecology or infection or biofilm or “Staphylococcus aureus” or “Aggregatibacter actinomycetemcomitans” or “Actinobacillus actinomycetemcomitans” or Fusobacterium or “Porphyromonas gingivalis” or “Bacteroides gingivalis” or “Prevotella intermedia” or Sphaerophorus or “Bacteroides intermedius” or “Tannerella forsythia” or “Treponema denticola” or Candida or (microbial adj1 (composition or diversity or flora)) or ((dental or oral or tooth) adj3 plaque)).ti,ab.

Analysis: exp Colony Count, Microbial/or exp polymerase chain reaction/or exp nucleic acid hybridization/or exp sequence analysis/or exp Fluorescent Antibody Technique/or exp In Situ Hybridization, Fluorescence/or exp Bacteriology/or exp genetic techniques/or (“colony forming unit*” or “colony-forming unit*” or CFU or quantification or ((bacteria* or colony) adj3 (count* or identif*)) or ((culture-independent or molecular or gene* or “nucleic acid” or bacteri* or microb* or microflora or microorganism* or sample*) adj6 (analy* or change* or unchange* or detect* or determin* or measure*)) or “polymerase chain reaction” or PCR or “checkerboard DNA-DNA hybridization” or immunfluorescence or (fluoresence adj1 (in-situ or “in situ” or insitu) adj1 (hybridisation or hybridization)) or FISH or pyrosequencing or pyrotag or culture or sequence or sequencing or genomic or proteomic or protein or transcriptomic or metabolomic or bacteriology).ti,ab.

Author Contributions

Conception, design, data acquisition, and interpretation were performed by L.K., F.G., P.S.; D.B.W. and P.R.S. drafted the text. W.D.B., P.R.S., and T.A. critically revised the manuscript. D.B.W. and P.S. performed the data analyses. The current study is part of and in parts identical with the doctoral thesis: “Systematische Übersichtsarbeit über das Mikrobiom von Peri-implantitis und Parodontitis. Gemeinsamkeiten, Unterschiede und Signifikanz für Forschung und Behandlung” submitted by Fabienne Gilli to the University of Zurich. All authors have read and agreed to the published version of the manuscript.

Funding

The study was supported by institutional funds of the University of Zurich.

Conflicts of Interest

The authors declare no conflict of interest.

References

  • 1.Van Velzen F.J., Ofec R., Schulten E.A., Ten Bruggenkate C.M. 10-year survival rate and the incidence of peri-implant disease of 374 titanium dental implants with a SLA surface: A prospective cohort study in 177 fully and partially edentulous patients. Clin. Oral Implants Res. 2015;26:1121–1128. doi: 10.1111/clr.12499. [DOI] [PubMed] [Google Scholar]
  • 2.Kuchler U., Chappuis V., Gruber R., Lang N.P., Salvi G.E. Immediate implant placement with simultaneous guided bone regeneration in the esthetic zone: 10-year clinical and radiographic outcomes. Clin. Oral Implants Res. 2016;27:253–257. doi: 10.1111/clr.12586. [DOI] [PubMed] [Google Scholar]
  • 3.Pjetursson B.E., Thoma D., Jung R., Zwahlen M., Zembic A. A systematic review of the survival and complication rates of implant-supported fixed dental prostheses (FDPs) after a mean observation period of at least 5 years. Clin. Oral Implants Res. 2012;23(Suppl. 6):22–38. doi: 10.1111/j.1600-0501.2012.02546.x. [DOI] [PubMed] [Google Scholar]
  • 4.Jung R.E., Zembic A., Pjetursson B.E., Zwahlen M., Thoma D.S. Systematic review of the survival rate and the incidence of biological, technical, and aesthetic complications of single crowns on implants reported in longitudinal studies with a mean follow-up of 5 years. Clin. Oral Implants Res. 2012;23(Suppl. 6):2–21. doi: 10.1111/j.1600-0501.2012.02547.x. [DOI] [PubMed] [Google Scholar]
  • 5.Derks J., Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J. Clin. Periodontol. 2015;42(Suppl. 16):S158–S171. doi: 10.1111/jcpe.12334. [DOI] [PubMed] [Google Scholar]
  • 6.Heitz-Mayfield L.J., Mombelli A. The therapy of peri-implantitis: A systematic review. Int. J. Oral Maxillofac. Implants. 2014;29:325–345. doi: 10.11607/jomi.2014suppl.g5.3. [DOI] [PubMed] [Google Scholar]
  • 7.Sahrmann P., Attin T., Schmidlin P.R. Regenerative treatment of peri-implantitis using bone substitutes and membrane: A systematic review. Clin. Implant Dent. Relat. Res. 2011;13:46–57. doi: 10.1111/j.1708-8208.2009.00183.x. [DOI] [PubMed] [Google Scholar]
  • 8.Monje A., Catena A., Borgnakke W.S. Association between diabetes mellitus/hyperglycaemia and peri-implant diseases: Systematic review and meta-analysis. J. Clin. Periodontol. 2017;44:636–648. doi: 10.1111/jcpe.12724. [DOI] [PubMed] [Google Scholar]
  • 9.De Araújo Nobre M., Maló P., Antune E. Influence of systemic conditions on the incidence of periimplant pathology: A case-control study. Implant Dent. 2014;23:305–310. doi: 10.1097/ID.0000000000000071. [DOI] [PubMed] [Google Scholar]
  • 10.Renvert S., Quirynen M. Risk indicators for peri-implantitis. A narrative review. Clin. Oral Implants Res. 2015;26(Suppl. 11):15–44. doi: 10.1111/clr.12636. [DOI] [PubMed] [Google Scholar]
  • 11.Vervaeke S., Collaert B., Cosyn J., De Bruyn H. A 9-Year Prospective Case Series Using Multivariate Analyses to Identify Predictors of Early and Late Peri-Implant Bone Loss. Clin. Implant Dent. Relat. Res. 2016;18:30–39. doi: 10.1111/cid.12255. [DOI] [PubMed] [Google Scholar]
  • 12.Heitz-Mayfield L.J. Peri-implant diseases: Diagnosis and risk indicators. J. Clin. Periodontol. 2008;35:292–304. doi: 10.1111/j.1600-051X.2008.01275.x. [DOI] [PubMed] [Google Scholar]
  • 13.Tecco S., Grusovin M.G., Sciara S., Bova F., Pantaleo G., Capparé P. The association between three attitude-related indexes of oral hygiene and secondary implant failures: A retrospective longitudinal study. Int. J. Dent. Hyg. 2018;16:372–379. doi: 10.1111/idh.12300. [DOI] [PubMed] [Google Scholar]
  • 14.Sanz M., Chapple I.L., Working Group 4 of the VIII European Workshop on Periodontology Clinical research on peri-implant diseases: Consensus report of Working Group 4. J. Clin. Periodontol. 2012;39(Suppl. 12):202–206. doi: 10.1111/j.1600-051X.2011.01837.x. [DOI] [PubMed] [Google Scholar]
  • 15.Belibasakis G.N., Charalampakis G., Bostanci N., Stadlinger B. Peri-implant infections of oral biofilm etiology. Adv. Exp. Med. Biol. 2015;830:69–84. doi: 10.1007/978-3-319-11038-7_4. [DOI] [PubMed] [Google Scholar]
  • 16.Paster B.J., Boches S.K., Galvin J.L., Ericson R.E., Dewhirst F.E. Bacterial diversity in human subgingival plaque. J. Bacteriol. 2001;183:3770–3783. doi: 10.1128/JB.183.12.3770-3783.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Steiger-Ronay V., Merlini A., Wiedemeier D.B., Schmidlin P.R., Attin T., Sahrmann P. Location of unaccessible implant surface areas during debridement in simulated peri-implantitis therapy. BMC Oral Health. 2017;17:137. doi: 10.1186/s12903-017-0428-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Świder K., Dominiak M., Grzech-Leśniak K., Matys J. Effect of Different Laser Wavelengths on Periodontopathogens in Peri-Implantitis: A Review of in vivo Studies. Microorganisms. 2019;7:189. doi: 10.3390/microorganisms7070189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Baehni P.C., Takeuchi Y. Anti-plaque agents in the prevention of biofilm-associated oral diseases. Oral Dis. 2003;9(Suppl. 1):23–29. doi: 10.1034/j.1601-0825.9.s1.5.x. [DOI] [PubMed] [Google Scholar]
  • 20.Teles R.P., Teles F.R. Antimicrobial agents used in the control of periodontal biofilms: Effective adjuncts to mechanical plaque control. Braz. Oral Res. 2009;23(Suppl. 1):39–48. doi: 10.1590/S1806-83242009000500007. [DOI] [PubMed] [Google Scholar]
  • 21.Matys J., Romeo U., Mroczka K., Grzech-Leśniak K., Dominiak M. Temperature Changes and SEM Effects of Three Different Implants-Abutment Connection during Debridement with Er: YAG Laser: An ex vivo Study. Materials (Basel) 2019;12:3748. doi: 10.3390/ma12223748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ronay V., Merlini A., Attin T., Schmidlin P.R., Sahrmann P. In vitro cleaning potential of three implant debridement methods. Simulation of the non-surgical approach. Clin. Oral Implants Res. 2017;28:151–155. doi: 10.1111/clr.12773. [DOI] [PubMed] [Google Scholar]
  • 23.Zijnge V., van Leeuwen M.B., Degener J.E., Abbas F., Harmsen H.J. Oral biofilm architecture on natural teeth. PLoS ONE. 2010;5:e9321. doi: 10.1371/journal.pone.0009321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.James P., Worthington H.V., Parnell C., Harding M., Riley P. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst. Rev. 2017;3:CD008676. doi: 10.1002/14651858.CD008676.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Apatzidou D.A. Modern approaches to non-surgical biofilm management. Front. Oral Biol. 2012;15:99–116. doi: 10.1159/000329674. [DOI] [PubMed] [Google Scholar]
  • 26.Renvert S., Lindahl C., Renvert H., Persson G.R. Clinical and microbiological analysis of subjects treated with Brånemark or AstraTech implants: A 7-year follow-up study. Clin. Oral Implants Res. 2008;19:342–347. doi: 10.1111/j.1600-0501.2007.01476.x. [DOI] [PubMed] [Google Scholar]
  • 27.Salvi G.E., Fürst M.M., Lang N.P., Persson G.R. One-year bacterial colonization patterns of Staphylococcus aureus and other bacteria at implants and adjacent teeth. Clin. Oral Implants Res. 2008;19:242–248. doi: 10.1111/j.1600-0501.2007.01470.x. [DOI] [PubMed] [Google Scholar]
  • 28.Rakic M., Grusovin M.G., Canullo L. The Microbiologic Profile Associated with Peri-Implantitis in Humans: A Systematic Review. Int. J. Oral Maxillofac. Implants. 2016;31:359–368. doi: 10.11607/jomi.4150. [DOI] [PubMed] [Google Scholar]
  • 29.Lafaurie G.I., Sabogal M.A., Castillo D.M., Rincón M.V., Chambrone L. Microbiome and Microbial Biofilm Profiles of Peri-Implantitis: A Systematic Review. J. Periodontol. 2017;88:1066–1089. doi: 10.1902/jop.2017.170123. [DOI] [PubMed] [Google Scholar]
  • 30.Belibasakis G.N., Mir-Mari J., Sahrmann P., Sanz-Martin I., Schmidlin P.R., Jung R.E. Clinical association of Spirochaetes and Synergistetes with peri-implantitis. Clin. Oral Implants Res. 2016;27:656–661. doi: 10.1111/clr.12690. [DOI] [PubMed] [Google Scholar]
  • 31.Faveri M., Figueiredo L.C., Shibli J.A., Pérez-Chaparro P.J., Feres M. Microbiological diversity of peri-implantitis biofilms. Adv. Exp. Med. Biol. 2015;830:85–96. doi: 10.1007/978-3-319-11038-7_5. [DOI] [PubMed] [Google Scholar]
  • 32.Sousa V., Nibali L., Spratt D., Dopico J., Donos N. Peri-implant and periodontal microbiome diversity in aggressive periodontitis patients: A pilot study. Clin. Oral Implants Res. 2017;28:558–570. doi: 10.1111/clr.12834. [DOI] [PubMed] [Google Scholar]
  • 33.Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J. Clin. Epidemiol. 2009;62:e1–e34. doi: 10.1016/j.jclinepi.2009.06.006. [DOI] [PubMed] [Google Scholar]
  • 34.Reynolds I., Duane B. Periodontal disease has an impact on patients’ quality of life. Evid. Based Dent. 2018;19:14–15. doi: 10.1038/sj.ebd.6401287. [DOI] [PubMed] [Google Scholar]
  • 35.Viechtbauer W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 2010;36:1–48. doi: 10.18637/jss.v036.i03. [DOI] [Google Scholar]
  • 36.Albertini M., López-Cerero L., O’Sullivan M.G., Chereguini C.F., Bullón P. Assessment of periodontal and opportunistic flora in patients with peri-implantitis. Clin. Oral Implants Res. 2015;26:937–941. doi: 10.1111/clr.12387. [DOI] [PubMed] [Google Scholar]
  • 37.Alcoforado G.A., Rams T.E., Feik D., Slots J. Aspects bacteriologiques des echecs des implants dentaires osteointegres che l’hommes. J. Prodontol. 1990;10:11–17. [Google Scholar]
  • 38.Arısan V., Karabuda Z.C., Arıcı S.V., Topçuoğlu N., Külekçi G. A randomized clinical trial of an adjunct diode laser application for the nonsurgical treatment of peri-implantitis. Photomed. Laser Surg. 2015;33:547–554. doi: 10.1089/pho.2015.3956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Ata-Ali J., Flichy-Fernández A.J., Alegre-Domingo T., Ata-Ali F., Palacio J., Peñarrocha-Diago M. Clinical, microbiological, and immunological aspects of healthy versus peri-implantitis tissue in full arch reconstruction patients: A prospective cross-sectional study. BMC Oral Health. 2015;15:43. doi: 10.1186/s12903-015-0031-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Augthun M., Conrads G. Microbial findings of deep peri-implant bone defects. Int. J. Oral Maxillofac. Implants. 1997;12:106–112. [PubMed] [Google Scholar]
  • 41.Bassetti M., Schär D., Wicki B., Eick S., Salvi G.E. Anti-infective therapy of peri-implantitis with adjunctive local drug delivery or photodynamic therapy: 12-month outcomes of a randomized controlled clinical trial. Clin. Oral Implants Res. 2014;25:279–287. doi: 10.1111/clr.12155. [DOI] [PubMed] [Google Scholar]
  • 42.Becker W., Becker B.E., Newman M.G., Nyman S. Clinical and microbiologic findings that may contribute to dental implant failure. Int. J. Oral Maxillofac. Implants. 1990;5:31–38. [PubMed] [Google Scholar]
  • 43.Bertone A.M., Rosa A.C., Nastri N., Santillán H.D., Jewtuchowicz V.M. Genetic-relatedness of peri-implants and buccal Candida albicans isolates determined by RAPD-PCR. Acta Odontol. Latinoam. 2016;29:197–205. [PubMed] [Google Scholar]
  • 44.Birang E., Talebi Ardekani M.R., Rajabzadeh M., Sarmadi G., Birang R., Gutknecht N. Evaluation of Effectiveness of Photodynamic Therapy with Low-level Diode Laser in Nonsurgical Treatment of Peri-implantitis. J. Lasers Med. Sci. 2017;8:136–142. doi: 10.15171/jlms.2017.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Bombeccari G.P., Guzzi G., Gualini F., Gualini S., Santoro F., Spadari F. Photodynamic therapy to treat periimplantitis. Implant Dent. 2013;22:631–638. doi: 10.1097/01.id.0000433592.18679.91. [DOI] [PubMed] [Google Scholar]
  • 46.Botero J.E., González A.M., Mercado R.A., Olave G., Contreras A. Subgingival microbiota in peri-implant mucosa lesions and adjacent teeth in partially edentulous patients. J. Periodontol. 2005;76:1490–1495. doi: 10.1902/jop.2005.76.9.1490. [DOI] [PubMed] [Google Scholar]
  • 47.Caccianiga G., Rey G., Baldoni M., Paiusco A. Clinical, Radiographic and Microbiological Evaluation of High Level Laser Therapy, a New Photodynamic Therapy Protocol, in Peri-Implantitis Treatment; a Pilot Experience. Biomed. Res. Int. 2016;2016:6321906. doi: 10.1155/2016/6321906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Canullo L., Penarrocha D., Micarelli C., Massidda O., Bazzoli M. Hard tissue response to argon plasma cleaning/sterilisation of customised titanium abutments versus 5-second steam cleaning: Results of a 2-year post-loading follow-up from an explanatory randomised controlled trial in periodontally healthy patients. Eur. J. Oral Implantol. 2013;6:251–260. [PubMed] [Google Scholar]
  • 49.Canullo L., Rossetti P.H., Penarrocha D. Identification of Enterococcus Faecalis and Pseudomonas Aeruginosa on and in Implants in Individuals with Peri-implant Disease: A Cross-Sectional Study. Int. J. Oral Maxillofac. Implants. 2015;30:583–587. doi: 10.11607/jomi.3946. [DOI] [PubMed] [Google Scholar]
  • 50.Canullo L., Peñarrocha-Oltra D., Covani U., Rossetti P.H. Microbiologic and Clinical Findings of Implants in Healthy Condition and with Peri-Implantitis. Int. J. Oral Maxillofac. Implants. 2015;30:834–842. doi: 10.11607/jomi.3947. [DOI] [PubMed] [Google Scholar]
  • 51.Canullo L., Radovanović S., Delibasic B., Blaya J.A., Penarrocha D., Rakic M. The predictive value of microbiological findings on teeth, internal and external implant portions in clinical decision making. Clin. Oral Implants Res. 2017;28:512–519. doi: 10.1111/clr.12828. [DOI] [PubMed] [Google Scholar]
  • 52.Casado P.L., Otazu I.B., Balduino A., de Mello W., Barboza E.P., Duarte M.E. Identification of periodontal pathogens in healthy periimplant sites. Implant Dent. 2011;20:226–235. doi: 10.1097/ID.0b013e3182199348. [DOI] [PubMed] [Google Scholar]
  • 53.Charalampakis G., Leonhardt Å., Rabe P., Dahlén G. Clinical and microbiological characteristics of peri-implantitis cases: A retrospective multicentre study. Clin. Oral Implants Res. 2012;23:1045–1054. doi: 10.1111/j.1600-0501.2011.02258.x. [DOI] [PubMed] [Google Scholar]
  • 54.Cortelli S.C., Cortelli J.R., Romeiro R.L., Costa F.O., Duarte P.M. Frequency of periodontal pathogens in equivalent peri-implant and periodontal clinical statuses. Arch. Oral Biol. 2013;58:67–74. doi: 10.1016/j.archoralbio.2012.09.004. [DOI] [PubMed] [Google Scholar]
  • 55.Da Silva E.S., Feres M., Figueiredo L.C., Shibli J.A., Ramiro F.S., Faveri M. Microbiological diversity of peri-implantitis biofilm by Sanger sequencing. Clin. Oral Implants Res. 2014;25:1192–1199. doi: 10.1111/clr.12231. [DOI] [PubMed] [Google Scholar]
  • 56.Dabdoub S.M., Tsigarida A.A., Kumar P.S. Patient-specific analysis of periodontal and peri-implant microbiomes. J. Dent. Res. 2013;92:S168–S175. doi: 10.1177/0022034513504950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.De Waal Y.C., Raghoebar G.M., Huddleston Slater J.J., Meijer H.J., Winkel E.G., van Winkelhoff A.J. Implant decontamination during surgical peri-implantitis treatment: A randomized, double-blind, placebo-controlled trial. J. Clin. Periodontol. 2013;40:186–195. doi: 10.1111/jcpe.12034. [DOI] [PubMed] [Google Scholar]
  • 58.De Waal Y.C., Eijsbouts H.V., Winkel E.G., van Winkelhoff A.J. Microbial Characteristics of Peri-Implantitis: A Case-Control Study. J. Periodontol. 2017;88:209–217. doi: 10.1902/jop.2016.160231. [DOI] [PubMed] [Google Scholar]
  • 59.Dörtbudak O., Haas R., Bernhart T., Mailath-Pokorny G. Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis. Clin. Oral Implants Res. 2001;12:104–108. doi: 10.1034/j.1600-0501.2001.012002104.x. [DOI] [PubMed] [Google Scholar]
  • 60.Ebadian A.R., Kadkhodazadeh M., Zarnegarnia P., Dahlén G. Bacterial analysis of peri-implantitis and chronic periodontitis in Iranian subjects. Acta Med. Iran. 2012;50:486–492. [PubMed] [Google Scholar]
  • 61.Faveri M., Gonçalves L.F., Feres M., Figueiredo L.C., Mayer M.P. Prevalence and microbiological diversity of Archaea in peri-implantitis subjects by 16S ribosomal RNA clonal analysis. J. Periodontal. Res. 2011;46:338–344. doi: 10.1111/j.1600-0765.2011.01347.x. [DOI] [PubMed] [Google Scholar]
  • 62.Gürlek Ö., Gümüş P., Nile C.J., Lappin D.F., Buduneli N. Biomarkers and Bacteria Around Implants and Natural Teeth in the Same Individuals. J. Periodontol. 2017;88:752–761. doi: 10.1902/jop.2017.160751. [DOI] [PubMed] [Google Scholar]
  • 63.Hultin M., Gustafsson A., Hallström H., Johansson L.A., Ekfeldt A., Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin. Oral Implants Res. 2002;13:349–358. doi: 10.1034/j.1600-0501.2002.130402.x. [DOI] [PubMed] [Google Scholar]
  • 64.Isehed C., Holmlund A., Renvert S., Svenson B., Johansson I., Lundberg P. Effectiveness of enamel matrix derivative on the clinical and microbiological outcomes following surgical regenerative treatment of peri-implantitis. A randomized controlled trial. J. Clin. Periodontol. 2016;43:863–873. doi: 10.1111/jcpe.12583. [DOI] [PubMed] [Google Scholar]
  • 65.Jankovic S., Aleksic Z., Dimitrijevic B., Lekovic V., Camargo P., Kenney B. Prevalence of human cytomegalovirus and Epstein-Barr virus in subgingival plaque at peri-implantitis, mucositis and healthy sites. A pilot study. Int. J. Oral Maxillofac. Surg. 2011;40:271–276. doi: 10.1016/j.ijom.2010.11.004. [DOI] [PubMed] [Google Scholar]
  • 66.Kumar P.S., Mason M.R., Brooker M.R., O’Brien K. Pyrosequencing reveals unique microbial signatures associated with healthy and failing dental implants. J. Clin. Periodontol. 2012;39:425–433. doi: 10.1111/j.1600-051X.2012.01856.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Leonhardt A., Renvert S., Dahlén G. Microbial findings at failing implants. Clin. Oral Implants Res. 1999;10:339–345. doi: 10.1034/j.1600-0501.1999.100501.x. [DOI] [PubMed] [Google Scholar]
  • 68.Leonhardt A., Dahlén G., Renvert S. Five-year clinical, microbiological, and radiological outcome following treatment of peri-implantitis in man. J. Periodontol. 2003;74:1415–1422. doi: 10.1902/jop.2003.74.10.1415. [DOI] [PubMed] [Google Scholar]
  • 69.Maruyama N., Maruyama F., Takeuchi Y., Aikawa C., Izumi Y., Nakagawa I. Intraindividual variation in core microbiota in peri-implantitis and periodontitis. Sci. Rep. 2014;4:6602. doi: 10.1038/srep06602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Máximo M.B., de Mendonça A.C., Renata Santos V., Figueiredo L.C., Feres M., Duarte P.M. Short-term clinical and microbiological evaluations of peri-implant diseases before and after mechanical anti-infective therapies. Clin. Oral Implants Res. 2009;20:99–108. doi: 10.1111/j.1600-0501.2008.01618.x. [DOI] [PubMed] [Google Scholar]
  • 71.Mombelli A., Feloutzis A., Brägger U., Lang N.P. Treatment of peri-implantitis by local delivery of tetracycline. Clinical, microbiological and radiological results. Clin. Oral Implants Res. 2001;12:287–294. doi: 10.1034/j.1600-0501.2001.012004287.x. [DOI] [PubMed] [Google Scholar]
  • 72.Neilands J., Wickström C., Kinnby B., Davies J.R., Svensäter G. Bacterial profiles and proteolytic activity in peri-implantitis versus healthy sites. Anaerobe. 2015;35:28–34. doi: 10.1016/j.anaerobe.2015.04.004. [DOI] [PubMed] [Google Scholar]
  • 73.Parthiban S., Ahmed N., Ramakrishnan T., Balakumar V., Raja M., Shekhar H. Herpes Simplex 1 and Periopathogen Role in Peri-implantitis. J. Contemp. Dent. Pract. 2017;18:399–404. doi: 10.5005/jp-journals-10024-2054. [DOI] [PubMed] [Google Scholar]
  • 74.Passariello C., Lucchese A., Pera F., Gigola P. Clinical, microbiological and inflammatory evicence of the efficacy of combination therpy including serratiopeptidase in the treatment of periimplantitis. Eur. J. Inflamm. 2012;10:463–472. doi: 10.1177/1721727X1201000322. [DOI] [Google Scholar]
  • 75.Persson G.R., Salvi G.E., Heitz-Mayfield L.J., Lang N.P. Antimicrobial therapy using a local drug delivery system (Arestin) in the treatment of peri-implantitis. I: Microbiological outcomes. Clin. Oral Implants Res. 2006;17:386–393. doi: 10.1111/j.1600-0501.2006.01269.x. [DOI] [PubMed] [Google Scholar]
  • 76.Persson G.R., Samuelsson E., Lindahl C., Renvert S. Mechanical non-surgical treatment of peri-implantitis: A single-blinded randomized longitudinal clinical study. II. Microbiological results. J. Clin. Periodontol. 2010;37:563–573. doi: 10.1111/j.1600-051X.2010.01561.x. [DOI] [PubMed] [Google Scholar]
  • 77.Persson G.R., Roos-Jansåker A.M., Lindahl C., Renvert S. Microbiologic results after non-surgical erbium-doped: Yttrium, aluminum, and garnet laser or air-abrasive treatment of peri-implantitis: A randomized clinical trial. J. Periodontol. 2011;82:1267–1278. doi: 10.1902/jop.2011.100660. [DOI] [PubMed] [Google Scholar]
  • 78.Renvert S., Lessem J., Dahlén G., Lindahl C., Svensson M. Topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridement of incipient peri-implant infections: A randomized clinical trial. J. Clin. Periodontol. 2006;33:362–369. doi: 10.1111/j.1600-051X.2006.00919.x. [DOI] [PubMed] [Google Scholar]
  • 79.Renvert S., Roos-Jansåker A.M., Lindahl C., Renvert H., Rutger Persson G. Infection at titanium implants with or without a clinical diagnosis of inflammation. Clin. Oral Implants Res. 2007;18:509–516. doi: 10.1111/j.1600-0501.2007.01378.x. [DOI] [PubMed] [Google Scholar]
  • 80.Renvert S., Samuelsson E., Lindahl C., Persson G.R. Mechanical non-surgical treatment of peri-implantitis: A double-blind randomized longitudinal clinical study. I: Clinical results. J. Clin. Periodontol. 2009;36:604–609. doi: 10.1111/j.1600-051X.2009.01421.x. [DOI] [PubMed] [Google Scholar]
  • 81.Renvert S., Widén C., Persson R.G. Cytokine and microbial profiles in relation to the clinical outcome following treatment of peri-implantitis. Clin. Oral Implants Res. 2017;28:1127–1132. doi: 10.1111/clr.12927. [DOI] [PubMed] [Google Scholar]
  • 82.Salcetti J.M., Moriarty J.D., Cooper L.F., Smith F.W., Offenbacher S. The clinical, microbial, and host response characteristics of the failing implant. Int. J. Oral Maxillofac. Implants. 1997;12:32–42. [PubMed] [Google Scholar]
  • 83.Sato J., Gomi K., Makino T., Kawasaki F., Yashima A., Ozawa T., Maeda N., Arai T. The evaluation of bacterial flora in progress of peri-implant disease. Aust. Dent. J. 2011;56:201–206. doi: 10.1111/j.1834-7819.2011.01324.x. [DOI] [PubMed] [Google Scholar]
  • 84.Sbordone L., Barone A., Ramaglia L., Ciaglia R.N., Iacono V.J. Antimicrobial susceptibility of periodontopathic bacteria associated with failing implants. J. Periodontol. 1995;66:69–74. doi: 10.1902/jop.1995.66.1.69. [DOI] [PubMed] [Google Scholar]
  • 85.Schmalz G., Tsigaras S., Rinke S., Kottmann T., Haak R., Ziebolz D. Detection of five potentially periodontal pathogenic bacteria in peri-implant disease: A comparison of PCR and real-time PCR. Diagn. Microbiol. Infect. Dis. 2016;85:289–294. doi: 10.1016/j.diagmicrobio.2016.04.003. [DOI] [PubMed] [Google Scholar]
  • 86.Schwarz F., Becker K., Rahn S., Hegewald A., Pfeffer K., Henrich B. Real-time PCR analysis of fungal organisms and bacterial species at peri-implantitis sites. Int. J. Implant Dent. 2015;1:9. doi: 10.1186/s40729-015-0010-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Shiba T., Watanabe T., Kachi H., Koyanagi T., Nakagawa I. Distinct interacting core taxa in co-occurrence networks enable discrimination of polymicrobial oral diseases with similar symptoms. Sci. Rep. 2016;6:30997. doi: 10.1038/srep30997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Shibli J.A., Melo L., Ferrari D.S., Figueiredo L.C., Faveri M., Feres M. Composition of supra- and subgingival biofilm of subjects with healthy and diseased implants. Clin. Oral Implants Res. 2008;19:975–982. doi: 10.1111/j.1600-0501.2008.01566.x. [DOI] [PubMed] [Google Scholar]
  • 89.Tada H., Masaki C., Tsuka S., Mukaibo T., Kondo Y., Hosokawa R. The effects of Lactobacillus reuteri probiotics combined with azithromycin on peri-implantitis: A randomized placebo-controlled study. J. Prosthodont. Res. 2018;62:89–96. doi: 10.1016/j.jpor.2017.06.006. [DOI] [PubMed] [Google Scholar]
  • 90.Tsigarida A.A., Dabdoub S.M., Nagaraja H.N., Kumar P.S. The Influence of Smoking on the Peri-Implant Microbiome. J. Dent. Res. 2015;94:1202–1217. doi: 10.1177/0022034515590581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Verdugo F., Castillo A., Castillo F., Uribarri A. Epstein-Barr virus associated peri-implantitis: A split-mouth study. Clin. Oral Investig. 2015;19:535–543. doi: 10.1007/s00784-014-1250-1. [DOI] [PubMed] [Google Scholar]
  • 92.Zhuang L.F., Watt R.M., Mattheos N., Si M.S., Lai H.C., Lang N.P. Periodontal and peri-implant microbiota in patients with healthy and inflamed periodontal and peri-implant tissues. Clin. Oral Implants Res. 2016;27:13–21. doi: 10.1111/clr.12508. [DOI] [PubMed] [Google Scholar]
  • 93.Ziebolz D., Schmalz G., Gollasch D., Eickholz P., Rinke S. Microbiological and aMMP-8 findings depending on peri-implant disease in patients undergoing supportive implant therapy. Diagn. Microbiol. Infect. Dis. 2017;88:47–52. doi: 10.1016/j.diagmicrobio.2017.02.008. [DOI] [PubMed] [Google Scholar]
  • 94.Kato A., Imai K., Sato H., Ogata Y. Prevalence of Epstein-Barr virus DNA and Porphyromonas gingivalis in Japanese peri-implantitis patients. BMC Oral Health. 2017;17:148. doi: 10.1186/s12903-017-0438-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Renvert S., Widén C., Persson G.R. Cytokine expression in peri-implant crevicular fluid in relation to bacterial presence. J. Clin. Periodontol. 2015;42:697–702. doi: 10.1111/jcpe.12422. [DOI] [PubMed] [Google Scholar]
  • 96.Yu X.L., Chan Y., Zhuang L., Lai H.C., Watt R.M. Intra-oral single-site comparisons of periodontal and peri-implant microbiota in health and disease. Clin. Oral Implants Res. 2019;30:760–776. doi: 10.1111/clr.13459. [DOI] [PubMed] [Google Scholar]
  • 97.Zheng H., Xu L., Wang Z., Li L., Chen F. Subgingival microbiome in patients with healthy and ailing dental implants. Sci. Rep. 2015;5:10948. doi: 10.1038/srep10948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Kröger A., Hülsmann C., Fickl S., Spinell T., Kebschull M. The severity of human peri-implantitis lesions correlates with the level of submucosal microbial dysbiosis. J. Clin. Periodontol. 2018;45:1498–1509. doi: 10.1111/jcpe.13023. [DOI] [PubMed] [Google Scholar]
  • 99.Jankovic S., Aleksic Z., Dimitrijevic B., Lekovic V., Milinkovic I., Kenney B. Correlation between different genotypes of human cytomegalovirus and Epstein-Barr virus and peri-implant tissue status. Aust. Dent. J. 2011;56:382–388. doi: 10.1111/j.1834-7819.2011.01360.x. [DOI] [PubMed] [Google Scholar]
  • 100.Eick S., Ramseier C.A., Rothenberger K., Brägger U., Buser D., Salvi G.E. Microbiota at teeth and implants in partially edentulous patients. A 10-year retrospective study. Clin. Oral Implants Res. 2016;27:218–225. doi: 10.1111/clr.12588. [DOI] [PubMed] [Google Scholar]
  • 101.Koyanagi T., Sakamoto M., Takeuchi Y., Ohkuma M., Izumi Y. Analysis of microbiota associated with peri-implantitis using 16S rRNA gene clone library. J. Oral Microbiol. 2010;2:5104. doi: 10.3402/jom.v2i0.5104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Sanz-Martin I., Doolittle-Hall J., Teles R.P., Patel M., Teles F.R.F. Exploring the microbiome of healthy and diseased peri-implant sites using Illumina sequencing. J. Clin. Periodontol. 2017;44:1274–1284. doi: 10.1111/jcpe.12788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Kumar P.S. Systemic Risk Factors for the Development of Periimplant Diseases. Implant Dent. 2019;28:115–119. doi: 10.1097/ID.0000000000000873. [DOI] [PubMed] [Google Scholar]
  • 104.Baumgart D.C., Sandborn W.J. Crohn’s disease. Lancet. 2012;380:1590–1605. doi: 10.1016/S0140-6736(12)60026-9. [DOI] [PubMed] [Google Scholar]
  • 105.Singh R.K., Chang H.W., Yan D., Lee K.M., Liao W. Influence of diet on the gut microbiome and implications for human health. J. Transl. Med. 2017;15:73. doi: 10.1186/s12967-017-1175-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Microorganisms are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES